Challenges in Drug Statistics and Data Collection Efforts
Explore the challenges faced in improving drug statistics and strengthening data collection efforts, including issues related to seizures, trafficking, price-purity data, cultivation, production, and manufacturing. This expert working group delves into complexities like data aggregation, attribution, transportation modes, and more in the context of drug-related activities. Gain insights into the hurdles encountered in gathering accurate information on drug trends and activities.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Expert working group on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ) 29-31 January 2018 Vienna, Austria
Challenges in data on seizures and trafficking Seizures (questions 1-3, ARQ Part 4) Aggregation of data from multiple law enforcement agencies Aggregation across drug types Attribution, counting rules for number of cases Losses Uncertainty about nature of seized substances Trafficking routes (questions 4-6, ARQ Part 4) Concepts of departure country, production/manufacturing country, transit and destination Require a significant effort of aggregation of case-specific records Mode of transportation (questions 7-8, ARQ Part 4) Potential overlap of mail with air/sea/land
Challenges in price-purity data (questions 15-18, ARQ Part 4) Prices Purchase units Currency Retail versus wholesale, redundant conversions Intelligence versus data Typical values and common ranges Ranges too wide, include extreme values Typical value unclear Size of samples Purity data Representativity Ad hoc concepts (cannabis, opium, tablet content) Purity-adjusted price
Challenges data on cultivation, production and manufacture Cultivation and eradication (Questions 32-38, ARQ Part 4) Relevance: cannabis, opium poppy and coca bush Indoor cultivation: no provision for reporting, unit of measurement Potential overlaps and ambiguities in measurement of eradication Yield and production (Questions 39-43, ARQ Part 4) Require in-depth studies Information currently available through joint crop monitoring projects Clandestine laboratories (Questions 48-57, ARQ Part 4) Nomenclature Breakdowns by substance, layout/structure Complex classifications Illicit manufacture (Questions 58-65, ARQ Part 4) Very specific information: precursor chemicals, raw materials and reagents used, and associated conversion ratios
